Clinical Trials List
2009-07-01 - 2011-06-30
Phase I
Terminated5
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wu-Chou Su Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chien-Wei Su Digestive System Department
- Rheun-Chuan Lee Division of Radiology
- Chung-Pin Li Digestive System Department
- Yi-Hsiang Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Hung-Chih Hsu Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Jen-Shi Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Shang-Hung Chen Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- 馮盈勳 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
- 陳威宇 Division of Hematology & Oncology
- 林明賢 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6/6 participants
-
Global
22/22 participants